AEGiS-Chicago Tribune: U.S. grant to help develop therapies: $4.5 million goes to NU researcher Chicago TribuneImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to Chicago Tribune main menu
DonateNow


U.S. grant to help develop therapies: $4.5 million goes to NU researcher

Chicago Tribune - September 30, 2004
Jon Van, Tribune staff reporter


New therapies for cancer, AIDS and other diseases will be the target of a Northwestern University researcher who Wednesday won a federal grant worth about $4.5 million.

Chad A. Mirkin, director of Northwestern's nanotechnology center, was one of nine scientists to win a Director's Pioneer Award from the National Institutes of Health.

Mirkin's past research has spawned two area companies, Nanosphere, based in Northbrook, and NanoInk, based in Chicago.

He was the only Midwest-based scientist to win a Pioneer Award, which was established this year. Some 1,350 scientists were nominated.

The Pioneer Award is intended to provide exceptional scientists with resources to pursue "high-risk, high-impact" research related to the improvement of human health.

Mirkin's earlier research produced tools that diagnose infections at very low levels and enable researchers to manipulate atoms and molecules using dip-pen lithography technology, a technique for inscribing materials onto a gold plate.

Mirkin said he intends to use the new federal funding to extend his research focus from diagnosing ills to providing therapies.

"We have forged a series of strong collaborations with medical doctors who are excited about using nanotechnology to explore how HIV infects individual cells and how it moves from one cell to another," said Mirkin.

His research will address fundamental questions such as whether one virus particle can invade a cell by itself, or if it requires several particles. Using tools Mirkin and his colleagues have developed over the past decade, he will place an individual virus particle next to a single cell to observe what happens.

"Most of what we know about this activity comes from averages of many viruses and many cells," he said.

"It's really exciting to work with individual cells, working at the nano-level, to try to understand what makes a certain virus particle potent.

"We want to learn how to deactivate it. This is central to designing therapies," Mirkin said.

The other eight researchers who won Pioneer Awards are based in Massachusetts, California, North Carolina and Texas.

Dr. Elias Zerhouni, NIH director, said his agency was impressed with the number and quality of nominees for the awards.

"By bringing the awardees' unique perspectives and creativity to bear on key medical research questions, these scientific pioneers may one day develop seminal theories or technologies that will propel science forward to improve human health," he said.


040930
CT040912


Copyright © 2004 - Chicago Tribune. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Chicago Tribune, Permissions Desk, 435 North Michigan Avenue, Chicago, IL 60611  http://www.chicagotribune.com

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .